Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02032758 · ClinicalTrials.gov registry record · Phase 4
Study of Arm and Putter Movement in Golfers With Golfer's Cramp
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 38
- Enrollment target
NCT02032758: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT02032758 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 38 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02032758, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 38 participants
- Enrollment target
Study Summary
The investigators will investigate golfers with visual evidence of an involuntary movement while putting before and after treatment with a low dose of propranolol.
Primary Outcome
"Dynamic change of rotation at impact" is the velocity of rotation of the putter from the start of the forward swing until the time of impact with the golf ball.
Interventions
- DRUG Propranolol
- DEVICE Opal Device
- PROCEDURE Science and Motion PuttLab (SAM)
- DEVICE Surface Electromyography EMG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-01 |
| Phase | Phase 4 |
What the finished NCT02032758 record still lists
NCT02032758 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 4 interventions - of which Propranolol is the first listed.
NCT02032758 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02032758 about?
NCT02032758 is a clinical study titled "Study of Arm and Putter Movement in Golfers With Golfer's Cramp". The investigators will investigate golfers with visual evidence of an involuntary movement while putting before and after treatment with a low dose of propranolol.
What is the current status of trial NCT02032758?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 38 participants. The study started on 2014-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02032758?
The interventions under investigation include: Propranolol (DRUG), Opal Device (DEVICE), Science and Motion PuttLab (SAM) (PROCEDURE), Surface Electromyography EMG (DEVICE).
Who is sponsoring clinical trial NCT02032758?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02032758's enrollment target sits among peer trials
38 1476th of 2000 higher than 519 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia